Search

Search Results

##search.searchResults.foundPlural##

Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

13-09-2023

https://doi.org/10.4081/dr.2023.9839

2187

PDF: 810

HTML: 22
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

19-05-2023

https://doi.org/10.4081/dr.2023.9692

896

PDF: 447

HTML: 15
Natural language processing of online support group postings reveals patients’ perspectives on strategies for managing psoriasis

Karan Rajalingam, Phillip M. Johansen, Nicole J. Levin, Jerry Qi, Oge Marques

11-09-2023

https://doi.org/10.4081/dr.2023.9824

739

PDF: 414

HTML: 19
Treatment satisfaction among patients with psoriasis in Saudi Arabia

Mahdi Aldhafiri, Rahaf Almutairi, Reem Albejais, Asma Almubark, Hussain Alwesaibie, Mohammed Albesher, Manayer Almustihi

15-04-2024

https://doi.org/10.4081/dr.2024.9967

783

PDF: 410

HTML: 15
Erythrodermic psoriasis treated with apremilast

John Arcilla, Daniel Joe, Johnathan Kim, Yohanan Kim, VuAnh N. Truong, Navin Jaipaul

19-09-2016

https://doi.org/10.4081/dr.2016.6599

1923

PDF: 865

HTML: 597
Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

Martina Burlando, Elena Campione, Aldo Cuccia, Giovanna Malara, Luigi Naldi, Francesca Prignano, Leonardo Zichichi

29-12-2022

https://doi.org/10.4081/dr.2023.9613

1592

PDF: 425

HTML: 70
Mortality risk factors in febrile ulceronecrotic Mucha- Habermann disease: a systematic review of therapeutic outcomes and complications

Vasiliki Tasouli-Drakou, May Nguyen, Hannah Guinn, Omron Hassan, Sneha Butala, Sheshanna Phan

21-11-2022

https://doi.org/10.4081/dr.2022.9492

1523

PDF: 588

HTML: 79
Anisakis simplex and urticaria. What we know about its real incidence and management in dermatological settings?

Sanja Javor, Donatella Bignardi, Matteo Borro, Cesare Massone

29-08-2023

https://doi.org/10.4081/dr.2023.9819

888

PDF: 579

HTML: 10
Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza

21-11-2022

https://doi.org/10.4081/dr.2022.9447

1166

PDF: 335

HTML: 38
Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen

11-10-2017

https://doi.org/10.4081/dr.2017.7079

1218

PDF: 575

HTML: 137
Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

Dimitris Rigopoulos, Aikaterini Patsatsi, Christina Antoniou, Dimitrios Sotiriadis, Angeliki Roussaki-Schulze, Nadia Boubouchairopoulou, Ioannis Skiadas, Vasillios Tsekouras, Ana Cristina Hernandez Daly

21-11-2022

https://doi.org/10.4081/dr.2022.9265

1387

PDF: 355

HTML: 20
Skin-directed therapy and biologic response modifiers in mycosis fungoides

Vieri Grandi, Virginia Alba Colantuono, Nicola Pimpinelli

07-05-2024

https://doi.org/10.4081/dr.2024.9926

448

PDF: 442
Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient

Nicoletta Bernardini, Nevena Skroza, Elisabeth Prevete, Federica Marraffa, Ilaria Proietti, Ersilia Tolino, Alessandra Mambrin, Giovanni Rossi, Salvatore Volpe, Giuseppe Bersani, Concetta Potenza

23-11-2022

https://doi.org/10.4081/dr.2022.9476

1225

PDF: 395

HTML: 23
A case of squamous cell carcinoma arising in a giant porokeratosis previously diagnosed as psoriasis

Lorry Aitkens, Joel Byrne, Charay Jennings-Dover, Kathryn Anne Potter

29-12-2022

https://doi.org/10.4081/dr.2023.9634

802

PDF: 371

HTML: 102
A retrospective comparative study of the efficacy and safety of two regimens of diphenylcyclopropenone in the treatment of recalcitrant alopecia areata

Tueboon Sriphojanart, Saranya Khunkhet, Poonkiat Suchonwanit

30-11-2017

https://doi.org/10.4081/dr.2017.7399

1954

PDF: 771

HTML: 246
Measuring the impact of pruritus in patients with epidermolysis bullosa: evaluation with an itch-specific instrument

Ashjan Alheggi, Raneem Alnutaifi, Manal Alkhonezan, Norah Almudawi, Renad Alsuhaibani, Philip Moons, Turki Aljuhani

18-05-2023

https://doi.org/10.4081/dr.2023.9700

1024

PDF: 278

APPENDIX S1: 111

HTML: 4
Molluscum contagiosum eruption during therapy with methotrexate and abatacept: a clinical and dermoscopic case study

Franca Taviti, Alessandra Calcinai, Federica Scarfì

21-03-2022

https://doi.org/10.4081/dr.2022.9259

848

PDF: 430

HTML: 489
A study on tumor necrosis factor-α single nucleotide polymorphisms and psoriasis vulgaris in Vietnam

Vinh Ngo Minh, Thiên Phúc Lý, Hao Nguyen Trong, Chuong Nguyen Hoang

12-04-2024

https://doi.org/10.4081/dr.2024.9899

823

PDF: 470

HTML: 17
Certolizumab to treat hidradenitis suppurativa

Asem Shadid, Saud Alobaida, Yousef Binamer

27-10-2022

https://doi.org/10.4081/dr.2022.9566

1732

PDF: 614

HTML: 23
Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

22-05-2023

https://doi.org/10.4081/dr.2023.9630

898

PDF: 470

HTML: 54
Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero

17-03-2022

https://doi.org/10.4081/dr.2022.9282

1016

PDF: 716

HTML: 39
CD4/CD8 double-negative mycosis fungoides: a review

Khalid Nabil Nagshabandi, Abdulrahman Shadid, Asem Shadid, Nouf K. Almuhanna

12-04-2024

https://doi.org/10.4081/dr.2024.9908

2920

PDF: 509

SUPPLEMENTARY: 50

HTML: 11
Erythrodermic psoriasis improved by tildrakizumab

Giampaolo Trevisan, Lerica Germi, Luigi Naldi

23-11-2022

https://doi.org/10.4081/dr.2022.9448

957

PDF: 521

HTML: 18
Methotrexate in the therapeutic pathway of patients with psoriasis. Analysis of clinical practice data and comparison with guidelines

Valeria Corazza, Francesco Cusano, Ornella De Pità, Luigi Rossi, G. Giovanni Virno

28-12-2021

https://doi.org/10.4081/dr.2022.9454

3981

PDF: 583

APPENDIX: 114

HTML: 11
Late reaction to ustekinumab infusion

Marina Resener Morais, Luana Pizarro Meneghello, Carina Flores de Oliveira, André Vicente Esteves Carvalho

e2

09-09-2013

https://doi.org/10.4081/dr.2013.e2

3812

PDF: 588

HTML: 259

1 - 25 of 31 items 1 2 > >>

Search

Search Results

Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Natural language processing of online support group postings reveals patients’ perspectives on strategies for managing psoriasis

Treatment satisfaction among patients with psoriasis in Saudi Arabia

Erythrodermic psoriasis treated with apremilast

Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

Mortality risk factors in febrile ulceronecrotic Mucha- Habermann disease: a systematic review of therapeutic outcomes and complications

Anisakis simplex and urticaria. What we know about its real incidence and management in dermatological settings?

Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

Skin-directed therapy and biologic response modifiers in mycosis fungoides

Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient

A case of squamous cell carcinoma arising in a giant porokeratosis previously diagnosed as psoriasis

A retrospective comparative study of the efficacy and safety of two regimens of diphenylcyclopropenone in the treatment of recalcitrant alopecia areata

Measuring the impact of pruritus in patients with epidermolysis bullosa: evaluation with an itch-specific instrument

Molluscum contagiosum eruption during therapy with methotrexate and abatacept: a clinical and dermoscopic case study

A study on tumor necrosis factor-α single nucleotide polymorphisms and psoriasis vulgaris in Vietnam

Certolizumab to treat hidradenitis suppurativa

Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

CD4/CD8 double-negative mycosis fungoides: a review

Erythrodermic psoriasis improved by tildrakizumab

Methotrexate in the therapeutic pathway of patients with psoriasis. Analysis of clinical practice data and comparison with guidelines

Late reaction to ustekinumab infusion

authors

reviewers

indexing

dermatopathology

Keywords